O

Organogenesis Holdings
D

ORGO

1.10500
USD
-0.03
(-2.64%)
Pre Open·1.11000USD+0.00500(+0.45%)
Last updated: · Delayed 15 min
Volume
201
EPS
0
Div Yield
-
P/E
-1
Market Cap
142,185,376
Overview
Related Instruments
CPT
CPT
D
Camden Property Trust
98.170
0.910(0.94%)
ESS
ESS
D
Essex Property Trust
269.69
0.27(0.10%)
INVH
INVH
D
Invitation Homes
26.805
0.265(1.00%)
MAA
MAA
D
Mid-America Apartment Communities
116.260
0.596(0.52%)
PLD
PLD
D
PROLOGIS
126.980
-3.610(-2.76%)
128.910+1.930(+1.52%)
SUI
SUI
D
Sun Communities
115.890
1.680(1.47%)
UDR
UDR
D
UDR
34.200
0.240(0.71%)
More

Title: Organogenesis Holdings

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.